OHI CFO Awarded Shares Equaling 7% of Outstanding Stock
OMEGA HEALTHCARE INVESTORS INC
Subscribe to track OHI
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
OHI CFO Awarded Shares Equaling 7% of Outstanding Stock
Company: OMEGA HEALTHCARE INVESTORS INC (OHI) Form: 4 | Filed: 2026-01-15 Significance: High
Insider: STEPHENSON ROBERT O Title: CHIEF FINANCIAL OFFICER | Relationship: Officer
Transaction: • Type: Grant (Profits Interest Units) • Shares: 20,799 • Price: $0.00 • Value: $0 • Owned After: 231,374 units
Key Insight: The CFO was granted derivative securities representing 7.05% of the company's total shares outstanding, a highly significant transaction indicating substantial potential shareholder dilution upon vesting.
Market Context: This is an equity award, not an open-market purchase. The units vest after a three-year cliff, aligning the CFO's interests with long-term performance.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: OMEGA HEALTHCARE INVESTORS INC (OHI)
Executive Summary
- Trading Significance: High
- Key Takeaway: The Chief Financial Officer, Robert O. Stephenson, was awarded 20,799 Profits Interest Units, which, based on the provided market data, represents a substantial 7.05% of the company's total shares outstanding.
- Market Impact: While the transaction is a $0 value grant, its size relative to the shares outstanding is exceptionally large, signaling significant potential dilution for existing shareholders upon vesting.
Company Information
| Field | Value |
|---|---|
| Company | OMEGA HEALTHCARE INVESTORS INC |
| Ticker Symbol | OHI |
| CIK | 0000888491 |
| Industry | REAL ESTATE INVESTMENT TRUSTS [6798] |
Insider Information
| Field | Value |
|---|---|
| Name | STEPHENSON ROBERT O |
| CIK | 0001157251 |
| Title/Position | CHIEF FINANCIAL OFFICER |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-01-13 |
| Transaction Code | A (Award) |
| Security Type | Profits Interest Units |
| Shares Involved | 20,799 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 231,374 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.00% |
| Shares Transacted | 20,799 |
| % of Shares Outstanding | 7.05% |
| Post-Transaction Ownership | 231,374 units (78.43% of outstanding) |
| Materiality Assessment | Highly Significant |
Impact Evaluation
- Market Cap Context: For a large-cap company with a $12.99 billion market capitalization, a $0 value transaction is typically immaterial. However, the materiality of this filing is not based on dollar value but on the number of shares granted.
- Ownership Concentration: Post-transaction, the CFO holds derivative securities representing an exceptionally high 78.43% of the company's stated shares outstanding. This level of insider ownership concentration is extraordinary.
- Dilution Impact: The grant of 20,799 units represents 7.05% of the 295,000 shares outstanding. This is a massive potential dilution event, far exceeding the 0.5% threshold for high significance. Upon vesting and conversion, this could significantly impact earnings per share and the value of existing shares.
- Transaction Significance: The transaction is rated Highly Significant due to the sheer volume of shares granted relative to the total shares outstanding. The percentage of shares (7.05%) is the primary driver of this assessment.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a scheduled equity award as part of executive compensation, not an open-market transaction reflecting immediate sentiment. The long vesting period (cliff on 12/31/2028) defers any market impact. However, the scale of potential dilution could be viewed negatively by the market if not previously anticipated.
Volume & Sentiment
- Expected Volume Impact: None. As this is not an open-market trade, it does not directly impact trading volume.
- Sentiment Indicator: Neutral. While grants align executive and shareholder interests, the magnitude of this award relative to shares outstanding introduces a significant dilution risk factor that could temper bullish sentiment.
Investment Insights
Positive Market Indicators
- The grant is designed to retain a key executive and align their compensation with long-term company performance, as indicated by the three-year vesting cliff.
Risk Factors
- Massive Potential Dilution: The grant represents over 7% of the company's shares outstanding, posing a substantial dilution risk to current shareholders.
- High Insider Concentration: The CFO's post-transaction holding of over 78% of the company (based on provided data) represents an extreme concentration of control and ownership, which can be a corporate governance concern.
Key Takeaways
- Dilution is the Story: The primary takeaway is the significant potential for shareholder dilution from this single grant.
- Long-Term Incentive: The award is a long-term incentive with a vesting date at the end of 2028, meaning the impact is not immediate.
- Unusual Scale: The size of the grant relative to the company's shares outstanding is exceptionally large and warrants close monitoring by investors.
Additional Context
Transaction Notes
- Security Type: The securities are "Profits Interest Units" which are contingent rights to receive one OP Unit, which is then redeemable for one share of OHI common stock. This is a common structure in REITs.
- Vesting Schedule: The units are subject to a three-year cliff vesting on December 31, 2028, contingent on continued employment.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
